Diabetes care in Qatar: a survey of pharmacists’ activities, attitudes and knowledge
Tóm tắt
Background Diabetes mellitus is recognized as a major public health issue and is one of the top ten causes of death in Qatar. Objective To describe the activities, and attitudes of Qatar pharmacists toward diabetes, to measure their diabetes knowledge and to assess their perceived barriers for diabetes care. Setting Community and ambulatory pharmacies in Qatar. Method Study objectives were addressed in a cross sectional survey of community and ambulatory pharmacists in Qatar. A phone call explaining the study was made to all community and ambulatory pharmacists in Qatar. Consenting pharmacists anonymously completed the survey either online or as paper. Main outcome measure Diabetes related activities, knowledge, attitudes and perceived barriers. Results Over 7 months, 126 surveys were collected (28% response rate). The majority of pharmacists always or often counselled patients on the appropriate time to take each medication and on medication side effects (90%, n = 100/111 and 73%, n = 81/111 respectively). Yet around 50% always or often provided education on the importance of screening for nephropathy (n = 59/112) and retinopathy (n = 58/109). In addition, 41% always or often provided education about the importance of immunization (n = 45/111) and 45% always or often provided therapy recommendations to physicians (n = 49/111). Using Diabetes Attitude Scale-3, most respondents had positive attitudes toward the need for special training, psychosocial impact of diabetes, and patient autonomy. Around 25% (n = 32/126) scored less than 6 out of 10 on the diabetes related knowledge test. The top three barriers for providing diabetes services were lack of time (53%, n = 67/126) shortage of personnel (42%, n = 53/126) and lack of private counseling area (42%, n = 53/126). Conclusion Qatar pharmacists mainly provide basic services for diabetic patients. They have an average diabetes related knowledge. Yet overall, they have positive attitudes toward diabetes, which is a vital component of any successful diabetes care service.
Tài liệu tham khảo
The World Health Organization, International Diabetes Federation. Diabetes action now. http://www.who.int/diabetes/actionnow/en/DANbooklet.pdf (2004). Accessed 5 May 2017.
The World Health Organization. Global report on diabetes. http://apps.who.int/iris/bitstream/10665/204871/1/9789241565257_eng.pdf?ua=1 (2016). Accessed 5 May 2017.
IDF Diabetes Atlas. 7th ed. http://www.diabetesatlas.org/.Accessed 5 May 2017.
Cranor CW, Christensen DB. The asheville project: short-term outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003;43:149–59.
Guirguis LM. Diabetes: are pharmacists making an impact on patient outcomes? CPJ/RPJ. 2003;136:24–8.
Cassels C. Poor diabetes management continues to leave millions at risk. http://www.medscape.com/viewarticle/539028 (2006). Accessed 5 May 2017.
National Diabetes Education Program. Redesigning the health care team: diabetes management and lifelong management. https://www.niddk.nih.gov/health-information/health-communication-programs/ndep/health-care-professionals/team-care/Documents/NDEP-37_508-2.pdf (2013). Accessed 5 May 2017.
The American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2017;40(suppl 1):S1–132.
Sisson E, Kuhn C. Pharmacist roles in the management of patients with type 2 diabetes. J Am Pharm Assoc. 2009;49(suppl 1):S41–5.
Pousinho S, Morgado M, Falcão A, Alves G. Pharmacist interventions in the management of type 2 diabetes mellitus: a systematic review of randomized controlled trials. J Manag Care Spec Pharm. 2016;22(5):493–515.
Campbell RK. Role of the pharmacist in diabetes management. Am J Health Syst Pharm. 2002;59(suppl 9):S18–21.
Ciardulli LM, Goode JR. Using health observances to promote wellness in community pharmacies. J Am Pharm Assoc. 2003;43(1):61–8.
The American Diabetes Association. National standards for diabetes self-management education and support. Diabetes Care. 2014;37(suppl 1):S144–53.
The International Diabetes Federation. International Standards for Education of Diabetes Health Professionals. https://www.idf.org/e-library/education.html (2015). Accessed 13 Oct 2017.
Armor BL, Britton ML, Dennis VC, Letassy NA. A review of pharmacist contributions to diabetes care in the United States. J Pharm Pract. 2010;23(3):250–64.
Wang Y, Yeo QQ, Ko Y. Economic evaluations of pharmacist-managed services in people with diabetes mellitus: a systematic review. Diabet Med. 2016;33(4):421–7.
Wubben DP, Vivian EM. Effects of pharmacist outpatient interventions on adults with diabetes mellitus: a systematic review. Pharmacotherapy. 2008;28:421–36.
Machado M, Bajcar J, Guzzo GC, Einarson TR. Sensitivity of patient outcomes to pharmacist interventions, part I: systematic review and meta-analysis in diabetes management. Ann Pharmacother. 2007;41(10):1569–82.
The IDF Diabetes Atlas, 7th ed. Qatar country report 2015. http://reports.instantatlas.com/report/view/846e76122b5f476fa6ef09471965aedd/QAT (2015). Accessed 5 May 2017.
World Health Organization. Qatar diabetes country profile. http://www.who.int/diabetes/country-profiles/qat_en.pdf?ua=1 (2016). Accessed 5 May 2017.
Bener A, Kim EJ, Mutlu F, Eliyan A, Delghan H, Nofal E, et al. Burden of diabetes mellitus attributable to demographic levels in Qatar: an emerging public health problem. Diabetes Metab Syndr. 2014;8(4):216–20.
Jackson C, Furnham A. Designing and analyzing questionnaires and surveys: a manual for health professionals and administrators. London: Whurr Publishers; 2000.
Younis WS, Campbell S, Slack MK. Pharmacists’ attitudes toward diabetes and their involvement in diabetes education. Ann Pharmacother. 2001;35(7–8):841–5.
Simpson S, Haggarty S, Johnson J, Schindel T, Ross T, Lewanczuk R. Survey of pharmacist activities and attitudes in diabetes management. Can Pharm J. 2009;142(3):127–34.
Fitzgerald JT, Funnell MM, Hess GE, Barr PA, Anderson RM, Hiss RG, et al. The reliability and validity of a brief diabetes knowledge test. Diabetes Care. 1998;21:706–10.
Chen HY, Lee TY, Huang WT, Chang CJ, Chen CM. The short-term impact of a continuing education program on pharmacists’ knowledge and attitudes toward diabetes. Am J Pharm Educ. 2004;68(5):121.
Anderson RM, Fitzgerald JT, Funnell MM, Gruppen LD. The third version of the Diabetes Attitude Scale. Diabetes Care. 1998;21(9):1403–7.
Diabetes Attitude Scale formula. http://diabetesresearch.med.umich.edu/peripherals/profs/documents/svi/das3_score.pdf. Accessed 5 May 2017.
Wibowo Y, Parsons R, Sunderland B, Hughes J. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey. Int J Clin Pharm. 2015;37(5):873–82.
Al Haqan A, Al-Taweel D, Awad A, Wake DJ. Pharmacists attitudes and role in diabetes management in Kuwait. Med Princ Pract. 2017;26:273–9.
Kjome RL, Sandberg S, Granås AG. Diabetes care in Norwegian pharmacies: a descriptive study. Pharm World Sci. 2008;30(2):191–8.
Shatnawi A, Latif DA. A qualitative assessment of West Virginia pharmacist activities and attitude in diabetes management. J Eval Clin Pract. 2016. https://doi.org/10.1111/jep.12677.
Shrestha M, Maharjan R, Prajapati A, Ghimire S, Shrestha N, Banstola A. Assessment of knowledge and practice of community pharmacy personnel on diabetes mellitus management in Kathmandu district: a cross sectional descriptive study. J Diabetes Metab Disord. 2015;14:71.
Douglas E, Power A, Hudson S. Pharmaceutical care of the patient with diabetes mellitus: pharmacists’ priorities for services and educational needs in Scotland. Int J Pharm Pract. 2007;15:47–52.
Andrews RC, Cooper AR, Montgomery AA, Norcross AJ, Peters TJ, Sharp DJ, et al. Diet or diet plus physical activity versus usual care in patients with newly diagnosed type 2 diabetes: the early ACTID randomised controlled trial. Lancet. 2011;378(9786):129–39.
Coppell KJ, Kataoka M, Williams SM, Chisholm AW, Vorgers SM, Mann JI. Nutritional intervention in patients with type 2 diabetes who are hyperglycaemic despite optimised drug treatment—lifestyle over and above drugs in diabetes (LOADD) study: randomised controlled trial. BMJ. 2010;341:c3337.
Ibrahim MM, Arafat Y, Awaisu A, Owusu Y, Colagiuri S, AlHafiz M. Association between stages of change and medication adherence among diabetic patients in a primary health care setting in Qatar: a preliminary study. Value Health. 2016;19(7):A676.
Bener A, Laftah F, Hamaq A, Daghash M, Abdullated W. A study of diabetes complications in an endogamous population: an emerging public health burden. Diabetes Metab Syndr. 2014;8(2):108–14.
Wilbur K, Al Amer M. An inventory of diabetes care in Qatar. Pract Diabetes Int. 2011;28(1):35–6.
El Hajj MS, Mahfoud ZR, Al Suwaidi J, Alkhiyami D, Alasmar AR. Role of pharmacist in cardiovascular disease-related health promotion and in hypertension and dyslipidemia management: a cross-sectional study in the State of Qatar. J Eval Clin Pract. 2016;22(3):329–40.
Wilbur K, Beniles A, Hammuda A. Physician perceptions of pharmacist roles in a primary care setting in Qatar. Glob Health. 2012;8:12.
Tawfik H, Bashwar Z, Al-Ali A, Salem M, Abdelbagi I. Improving physician’s adherence to completing vaccination schedules for patients with type 2 diabetes attending non-communicable diseases clinics in West Bay Health Center, Qatar. BMJ Qual Improv Rep. 2015;4(1):u208497.w3388.
American Society of Health System Pharmacists Council on Professional Affairs. ASHP guidelines on the pharmacist’s role in immunization. Am J Health Syst Pharm. 2003;60(13):1371–7.
Bisheya AF, El-Mijbri SB, Beshyah SA, Sherif I. Community pharmacists’ knowledge, attitude and practice towards diabetes care in Tripoli, Libya. Ibnosina J Med Biomed Sci. 2011;3(3):89–95.
The Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group. Effect of intensive diabetes therapy on the progression of diabetic retinopathy in patients with type 1 diabetes: 18 years of follow-up in the DCCT/EDIC. Diabetes. 2015;64:631–42.
The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med. 2000;342:381–9.
UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34. Lancet. 1998;352:854–65.
Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group, Nathan DM, Zinman B, Cleary PA, Backlund JY, Genuth S, Miller R, et al. Modern-day clinical course of type 1 diabetes mellitus after 30 years’ duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh. Epidemiology of diabetes complications experience (1983–2005). Arch Intern Med. 2009;169:1307–16.
El Hajj MS, Al-Saeed HS, Khaja M. Qatar pharmacists’ understanding, attitudes, practice and perceived barriers related to providing pharmaceutical care. Int J Clin Pharm. 2016;38(2):330–43.
El Hajj MS, Kheir N, Al-Zaidan MB, Jewesson PJ. Pharmacist characteristics, medication use perceptions and professional satisfaction: a first national survey in the state of Qatar. J Healthc Leadersh. 2011;3:9–28.